(646) 415-8515 -or- 877-WHY-SMOKE Call Monday-Saturday 10 AM to 10 PM
Clinical Trials
In May 2003, an Institutional Review Board (IRB) authorized investigational clinical trials using low-level laser therapy in compliance with FDA regulations. Clinical trials have been set up to measure the safety and effectiveness of low-level laser therapy to treat nicotine addiction. The IRB is an organization chartered by the Food and Drug Administration (FDA) to oversee clinical trials, which collect data on new medical treatments. Institutional Review Boards exist to ensure the rights of human study subjects in clinical research trials; all treatment being offered must be safe, as well as ethical.
The FDA has already ruled low-level laser therapy as a “non-significant risk” and the US investigational trials are being funded through patient participation. New Life is the first full scale nicotine addiction based clinic in New York City participating in this research study to test the effectiveness of smoking cessation treatment. Call us today, to see if you qualify to participate in this exciting clinical trial. Call 646-415-8515 to speak with a technician today.
New Life Laser Therapy
274 Madison Avenue Suite 1003
New York, NY 10016
646-415-8515 questions@newlifenyc.com
